Bullous Pemphigoid Induced by Metamizole in a Pediatric Patient

Area of Science:

• Dermatology
• Autoimmune diseases
• Pediatric medicine

Background:

• Bullous pemphigoid (BP) is a rare autoimmune blistering disease primarily affecting adults.
• The exact causes of BP are unknown, but potential triggers include medications, infections, and vaccinations.
• Pediatric cases of bullous pemphigoid are exceptionally uncommon.

Purpose of the Study:

• To report a rare case of bullous pemphigoid in a pediatric patient.
• To investigate the potential link between metamizole use and the development of bullous pemphigoid in an adolescent.
• To highlight the importance of considering drug-induced etiology in pediatric bullous diseases.

Main Methods:

• Clinical presentation and diagnostic workup of a 14-year-old patient with suspected bullous pemphigoid.
• Histopathological examination of skin biopsy for confirmation of diagnosis.
• Review of patient's medication history, specifically focusing on metamizole use.

Main Results:

• A 14-year-old patient presented with clinical features consistent with bullous pemphigoid.
• Diagnosis was confirmed through histopathological analysis of skin biopsy.
• The onset of bullous pemphigoid coincided with the patient's use of metamizole.

Conclusions:

• Metamizole may be a potential trigger for bullous pemphigoid in the pediatric population.
• This case underscores the importance of thorough medication review in diagnosing pediatric autoimmune blistering diseases.
• Further research is warranted to explore drug-induced bullous pemphigoid in children.